Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
RO 28-2653 exhibits anti-invasive, antitumoral, and antiangiogenic efficacy and is also classified as an orally active and selective matrix metalloproteinases inhibitor.
您的位置：
